Research And Markets Research And Markets

Russian Pharmaceuticals Market 2009

  • ID: 1207583
  • March 2010
  • Region: Russia
  • 26 Pages
  • DSM Group
1 of 4

Analytical review of pharma market in Russia

New market research from DSM group, one of Russia’s leading market research agencies, shows that despite a background of falling GDP and primary economic indicators for the country, the Russian pharma market in 2009 was able to show growth in ruble terms. The overall value of the pharma market in 2009 amounted to 538 billion rubles (including VAT) in retail prices, 18% higher compared to the previous year. This compares to an overall decline in GDP of -8%.

The Russian pharma market comprises the commercial segment, parapharmaceutical segment and the state-owned medicine segment. Growth was seen across all three with the commercial pharmaceuticals segment growing 22%, driven primarily by price increases, as a result of the higher costs on imported medicines given the weakness of the ruble,the state segment growing by 11% and parapharmaceuticals growing by 15%. Sales for the commercial segment in 2009 were approximately 290 billion rubles ($9.1 billion), sales for the state sector were approximately 133 billion rubles ($4.2 billion), and for parapharmaceuticals were approximately 116 billion rubles ($3.7 billion).

DSM is forecasting the Russian pharmaceutical market will grow by more than 11% in 2010 in ruble terms READ MORE >

Note: Product cover images may vary from those shown
2 of 4

1. Capacity of Russia’s pharmaceutical market
2. Manufacturers
3. Pharmacy chains
4. Distributors
5. Pharmaceutical market growth drivers

Note: Product cover images may vary from those shown
3 of 4

DSM Group is the leading marketing agency on the pharmaceutical market in Russia. It is part of the European Society for Opinion and Marketing Research (ESOMAR). The retail audit of the Russian pharmaceutical market conducted by DSM Group is ISO 9001:2000 compliant.

A large-scale study of the Russian pharmaceutical industry backed by regular market monitoring is among the latest implemented projects. The findings of this study are shown in this analytical survey, which encompasses the main trends and all sectors of the pharmaceutical industry, such as manufacturing, distribution, and retail business. The survey report is targeted to international audiences.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown